Purpose Patient care involving genetics is challenging for nongenetics health-care providers.
Clinical decision support (CDS) tools are a potential solution because they provide patient-…

Background We explored health professionals’ views on the utility of circulating tumor DNA (ctDNA)
testing in hereditary cancer syndrome (HCS) management. Materials and Methods A …

… Author links open overlay panel Agnes Sebastian a 1 , S. Sanju a 1 , Paresh Jain b , …
Agnes. S and S. Sanju were responsible for acquisition of data, analysis, interpretation of …

Background: Real-world evidence (RWE) can provide postmarket data to inform whether
funded cancer drugs yield expected outcomes and value for money, but it is unclear how to …

Most secondary genomic findings (SFs) fall in the scope of primary care practice. However,
primary care providers' (PCPs) capacity to manage these findings is not well understood. We …

The development of technology has led to the sales and purchases of products and services
online. However, the absence of a physical store prevents the prospective buyers from …

Primary care providers will increasingly be tasked with managing most secondary findings
from genomic sequencing, but literature exploring their capacity to manage findings beyond …

Purpose Genomic sequencing can generate complex results, including variants of uncertain
significance (VUS). In general, VUS should not inform clinical decision-making. This study …

We aimed to describe patient preferences for a broad range of secondary findings (SF) from
genomic sequencing (GS) and factors driving preferences. We assessed preference data …

Variants of uncertain significance (VUS) are frequently reclassified but recontacting patients
with updated results poses significant resource challenges. We aimed to characterize public …